TrialA Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns
Trial details
- Registry ID
- NCT02148705
- Phase
- Phase 3
MDWD
MediWound Ltd
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
4Trials in this database
1Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal BurnsNCT02148705 | MDWD | Phase 3 | Completed | 2018-06-12Actual |
| A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of CareNCT02278718 | MDWD | Phase 3 | Completed | 2021-04Actual |
| A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)NCT06568627 | MDWD | Phase 3 | Recruiting | 2026-12Estimated |
| Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg UlcersNCT06690177 | MDWD | Phase 2 | Not yet recruiting | 2027-12-30Estimated |
A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care
Trial details
- Registry ID
- NCT02278718
- Phase
- Phase 3
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
Trial details
- Registry ID
- NCT06568627
- Phase
- Phase 3
Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers
Trial details
- Registry ID
- NCT06690177
- Phase
- Phase 2
Latest recorded trial changes
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
NCT06568627 · MediWound Ltd
Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Compare wording
− Before
Measure: Incidence of complete debridement, clinically (visually) assessed after each application
Measure: Incidence of complete wound closure
+ After
Measure: Incidence of complete debridement, clinically (visually) assessed after each application Measure: Facilitation of wound closure, clinically assessed, as measured by time to complete wound closure